Yi Larson

Ms. Yi Larson is an Independent Director at Olema Pharmaceuticals, Inc. and a President, Chief Executive Officer & Director at Expedition Therapeutics, Inc. She is on the Board of Directors at Olema Pharmaceuticals, Inc. and Expedition Therapeutics, Inc. Ms. Larson was previously employed as a Chief Financial Officer by LianBio, an Independent Director by Rayzebio, Inc., a Chief Financial Officer & Executive Vice President by Turning Point Therapeutics, Inc., and a Managing Director-Healthcare Investment Banking by Goldman Sachs & Co. LLC.
She received her undergraduate degree from Massachusetts Institute of Technology, a graduate degree from Massachusetts Institute of Technology and an MBA from The Wharton School of the University of Pennsylvania.